Bayer to Invest More Than EUR400 Million on Contraception-Production Sites
05 Octubre 2021 - 2:20AM
Noticias Dow Jones
By Cristina Roca
Bayer AG said Tuesday that it will spend more than 400 million
euros ($464.8 million) to expand its production capabilities as
part of its goal of increasing access to contraception for women in
less wealthy countries.
The German pharmaceutical-and-chemical conglomerate will build a
new production facility in Alajuela, Costa Rica. It will also build
a new facility and expand its production capability in Turku,
Finland, the company said.
Both sites will produce hormonal implants and hormonal
intrauterine systems, and will support the company's goal of giving
100 million women in low- and middle-income countries access to
family planning by 2030, Bayer said.
Write to at cristina.roca@wsj.com
(END) Dow Jones Newswires
October 05, 2021 03:05 ET (07:05 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Bayer (TG:BAYN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024